Lifescient, Inc.

792 Grand Avenue
South San Francisco, CA 94080
United States

Contact: Renee Sera, Chief Administrative Officer

Phone: 415-810-2021

Industries
  • Biotechnology
  • Healthcare
Company Type
  • Private company (not backed by venture capital firms)
Financing Stage
  • Seed
Financing Type
  • Equity capital
Financing Amount
  • $1 million - $5 million
Board of directors
  • Kamalesh Rao, Kamalesh has over 25 years of experience in the development of pharmaceuticals and product approvals. He played a pivotal role in the chemical development of Probuphine, the first ever LAI formulation to deliver long-lasting medication to treat people addicted to opioids. Kamalesh has experience in the development of sustained release, long-acting injectable and long-acting solid and in situ gel implant dosage forms.